Moderna, Memorial Sloan Kettering Cancer Center, and American Cancer Society are developing personalized cancer vaccine technology.
1 report, 1 independent
Updated Aug 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Moderna, Memorial Sloan Kettering Cancer Center, and American Cancer Society are developing personalized cancer vaccine technology.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Moderna
American biotechnology company
-
Memorial Sloan Kettering Cancer Center
cancer treatment and research institution in New York City, United States
-
American Cancer Society
health organization seeking to cure and treat cancer
Related events
- Moderna, Merck, and Georgetown Lombardi Comprehensive Cancer Center are collaborating on developing a personalized cancer vaccine combination.
- Moderna announced a collaboration with Merck KGaA regarding a personalized cancer vaccine platform.
- Analyst comments on industry trends regarding Moderna's competition in the cancer vaccine market.
- Moderna and Merck KGaA are working on personalized melanoma shots, with manufacturing challenges being discussed by Amy Walker.
- Moderna and Merrill jointly developed skin cancer vaccine trials.